Overview

Impact of Vitamin D Repletion in Hemodialysis Patients

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
0
Participant gender:
All
Summary
Dialysis patients often suffer from defects in their immune system (that part of the body which fights infection). Evidence suggests that Vitamin D deficiency may have a negative effect on immunity, and many dialysis patients are deficient in Vitamin D. We believe that by giving Vitamin D to dialysis patients who are deficient, we may help improve their immune system. This study will test that idea.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Mehrotra, Anita, M.D.
Collaborators:
American Heart Association
National Kidney Foundation
Treatments:
Cholecalciferol
Ergocalciferols
Vitamin D
Vitamins
Criteria
Inclusion Criteria:

1. Age > 18 years

2. Chronic hemodialysis treatments for at least 2 consecutive months

3. 25OH-Vitamin D level < 25 ng/mL (inclusion criteria for randomization)

Exclusion Criteria:

1. History of acute renal failure requiring dialysis with potential for renal recovery

2. History of HIV/AIDS

3. Inability to provide informed consent